The technology of the Gx Inbeneo^®:

Ideal for biopharmaceuticals and APIs

We, Midas Pharma GmbH and Gerresheimer AG, decided to join forces and develop the next–generation pre–pressurized & cartridge–based autoinjector. The product offers biotech and pharma companies new possibilities in the treatment of patients with various diseases.

Our Next-Generation Autoinjector

Platform technology designed to fit drug formulations with different properties

Customizable spring force
Customizable subcutaneous needle 25, 27, and 29G Thin Wall gauge
Compatible with 1.5 and 3.0 mL ISO cartridges
Intended for low and high viscosity (e.g. 100 cP)
Adaptation for I.M. injections possible
Adaptation for 5.0 mL cartridges possible

Customer’s benefits

Single-use autoinjector for subcutaneous injection

Cartridge-based, pre-pressurized cartridge
Double-sided needle system for reduced injection time
No contact between the needle and the drug during storage (dry needle)
Cartridge with baked-on siliconization is possible
Terminal gas sterilization compatible with biologics
Air bubble size decrease in cartridge due to pressure
No seperate spring release mechanism

Read the latest publications on the Gx Inbeneo

Discover how the Gx Inbeneo autoinjector was purpose-designed to provide an effective, easy-to-use solution for the subcunateous self-administration of sensitive biopharmaceuticals.

Find out more